Fungal antibiotics bu-3608, bu-3608b and bu-3608c
CA 1309045 C · Owner: Bristol-Myers Squibb Company · Inventors: Konishi, Masataka; Tomita, Koji; Tomatsu, Kozo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel antibiotic herein designated as BU-3608 BU-3608, B, and BU-3608 C are produced by fermentation of Actinomadura hibisca Strain No. P157-2 ATCC 53S57, and, Strain No. Q278-4, ATCC 53646. The antibiotics possess antifungal and antiviral activities.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted October 20, 1992. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended October 20, 2009.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.